| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/21/2002 | CA2421792A1 Alpha v integrin receptor antagonists |
| 03/21/2002 | CA2421786A1 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 03/21/2002 | CA2421652A1 Alpha v integrin receptor antagonists |
| 03/21/2002 | CA2421279A1 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2420493A1 Use of carnitine for enhancing training-induced bradycardia |
| 03/21/2002 | CA2420450A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188773A1 Nitroderivatives of polysaccharides |
| 03/20/2002 | EP1188755A1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 03/20/2002 | EP1188747A1 Phenoxypropylamine compounds |
| 03/20/2002 | EP1188440A1 Medicinal composition for oral administration |
| 03/20/2002 | EP1188438A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| 03/20/2002 | EP1188437A2 Beta-hydroxybutyric acid or acetoacetic acid or salts or esters therof for use in improving cerebral function |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187911A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187838A1 Thiazolopyrimidines useful as tnf-alpha inhibitors |
| 03/20/2002 | EP1187836A1 Substituted imidazothiazoles as antidepressant agents |
| 03/20/2002 | EP1187831A1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 03/20/2002 | EP1187829A1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 03/20/2002 | EP1187827A1 Antiviral agents |
| 03/20/2002 | EP1187816A1 5-cyano-2-aminopyrimidine derivatives |
| 03/20/2002 | EP1187815A1 4-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187814A2 5-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/20/2002 | EP1187812A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 03/20/2002 | EP1187811A1 Inhibitors of metalloproteinases |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/20/2002 | EP1187628A2 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
| 03/20/2002 | EP1187618A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use |
| 03/20/2002 | EP1187616A1 Thrombin inhibitors |
| 03/20/2002 | EP1187606A1 Pharmaceutical composition containing sibutramine and orlistat |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP1187531A1 Macrophage scavenger receptor antagonists |
| 03/20/2002 | EP1137415A4 Myt1 kinase inhibitors |
| 03/20/2002 | EP1077687B1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | EP0888356B1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 03/20/2002 | EP0777680B1 Urokinase receptor ligands |
| 03/20/2002 | EP0730458B1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 03/20/2002 | EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 03/20/2002 | CN1341103A Pyridazin-3-one derivatives and medicines containing the same |
| 03/20/2002 | CN1341099A 2-aminopyridines containing fused ring substituents |
| 03/20/2002 | CN1341027A Inhibitors for use in hemostasis and immune function |
| 03/20/2002 | CN1340351A Powdered medicine 'Tongluosan' and its preparing process |
| 03/20/2002 | CN1340344A Prescription of 'strong heart first-aid dropping pill' and its preparing process |
| 03/20/2002 | CN1081187C Inhibitors of prenuyl transferases |
| 03/20/2002 | CN1081061C Medicinal pill for treating piles |
| 03/20/2002 | CN1081052C Fast-acting piles-treating Chinese medicine preparation |
| 03/19/2002 | US6359182 C-nitroso compounds and use thereof |
| 03/19/2002 | US6359181 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 03/19/2002 | US6359158 A 16-hydroxyeicosatetraenoic acid antagonist; antiinflammatory agents |
| 03/19/2002 | US6359145 Imidazole compounds |
| 03/19/2002 | US6359130 Bridged indenopyrrolocarbazoles |
| 03/19/2002 | US6359011 Denaturants for sympathomimetic amine salts |
| 03/19/2002 | US6358991 By administering indole compounds such as 1-(4-(2-azepan-1yl-ethoxy)-benzyl)-2-(4-hydroxy-phenyl)-3-methyl-1h-indol-5 -ol; epilepsy, asthma, eating disorders, obesity, neurodegenertive conditions, schizophrenia |
| 03/19/2002 | US6358989 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/19/2002 | US6358985 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358984 For therapy of hypertension and/or diseases such as heart and renal diseases |
| 03/19/2002 | US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 03/19/2002 | US6358978 Substituted benzimidazoles |
| 03/19/2002 | US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration |
| 03/19/2002 | US6358970 Integrin receptor antagonists |
| 03/19/2002 | US6358967 Ergoline amine derivatives with blood pressure lowering effect |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358956 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358924 GLP-1 formulations |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |
| 03/19/2002 | US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system |
| 03/19/2002 | US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects |
| 03/19/2002 | US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis |
| 03/19/2002 | US6358536 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 03/19/2002 | CA2251453C 5-arylalkyl-substituted pyrazolo(4,3-d)pyrimidine-7-ones |
| 03/19/2002 | CA2250036C Antibiotic cocktail and method of use |
| 03/19/2002 | CA2236673C (-)cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 03/19/2002 | CA2179521C 2,4-disulphophenyl butylnitrone, its salts and their use as pharmaceuti cal spintraps |
| 03/19/2002 | CA2128287C Benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them |
| 03/19/2002 | CA2084082C 1-pyperidinyl alkanoylarysulfonamide derivatives |
| 03/19/2002 | CA2032797C Antithrombotic compounds |
| 03/18/2002 | CA2319928A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002021141A2 Methods and compositions for diseases associated with amyloidosis |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | WO2002020807A1 L-methionine $g(g)-lyase with modified function |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020768A2 Caveolin peptides and their use as therapeutics |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020609A2 Interleukin-11 for the treatment of stroke and neuropathies |
| 03/14/2002 | WO2002020530A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |